Keros Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $306.8M
Liabilities Breakdown FY2022
Total Liabilities: $29.4M
Asset Breakdown
Total Assets: $306.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $279.0M | 91.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.0M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $25.7M | 8.4% |
Liabilities Breakdown
Total Liabilities: $29.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 11.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $26.0M | 88.6% |